Navigating the Accelerated Approval Withdrawal Process: A Clear Path for Sponsors
Introduction The FDA’s draft guidance Expedited Program for Serious Conditions—Accelerated Approval of Drugs and Biologics proposes an accelerated approval pathway, which would expedite access to...
Read The Article